맞춤형 항체 서비스 시장 : 서비스별, 유형별, 공급원별, 용도별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Custom Antibody Services Market By Service , By Type By Source By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,228,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,432,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

맞춤형 항체 서비스 시장

맞춤형 항체 서비스 시장은 2023년 6억 달러로 평가되었고, 2024-2033년 연평균 8.7% 성장하여 2033년에는 14억 달러에 이를 것으로 예상됩니다.

맞춤형 항체 서비스는 사용자의 요청에 따라 항체를 제작하는 서비스입니다. 항체는 진단, 연구 및 치료 목적에 맞게 특별히 조정됩니다. 맞춤형 항체 서비스의 가장 큰 장점은 항원에 대한 항체의 특이성을 확보할 수 있어 신뢰할 수 있는 실험 결과를 얻을 수 있다는 점입니다. 또한, 항체에 다양한 변형을 가할 수 있는 유연성은 고객에게 맞춤형 항체 서비스의 장점을 더욱 돋보이게 합니다.

표적 치료를 위한 맞춤 의료의 인기가 높아짐에 따라 의료 부문에서 맞춤형 항체 서비스의 채택이 증가하고 있습니다. 또한, 제약 및 생명공학 기업들이 R&D 활동을 강화하기 위해 지출을 늘리고 있는 것도 시장 성장에 크게 기여하고 있습니다. 맞춤형 항체 서비스 시장의 미래는 재조합 기술과 새로운 항체 트렌드에 의해 재정의될 것으로 예상되며, AI와 ML 알고리즘은 항체 설계를 지원하고 단일 도메인 항체, 이중 특이성 항체, 항체 조각과 같은 차세대 항체를 개발할 수 있도록 지원할 준비가 되어 있습니다.

그러나 높은 항체 생산 비용과 긴 개발 기간으로 인해 맞춤형 항체 서비스 시장의 성장을 저해하고 있습니다. 또한, 항체 허가를 위해 확립된 품질 관리 조치와 검증 프로세스는 매우 엄격하고 시간이 많이 걸립니다. 이러한 기준을 효율적으로 준수하는 것은 시장 성장을 지연시킵니다. 이와는 대조적으로, 의약품 개발 및 연구 개발에 대한 투자가 증가함에 따라 맞춤형 항체 서비스 시장은 몇 가지 유리한 성장 기회를 확인할 것으로 예상됩니다. 세계 데이터 비즈니스 인텔리전스 플랫폼인 Statista에 따르면 미국은 2022년 의약품에 6,030억 달러를 투자할 것으로 추정됩니다. 또한, 미국 제약사들은 매출의 약 21%를 연구개발에 투자하고 있습니다. 이러한 지출은 맞춤형 항체 서비스 시장의 미래가 유망하다는 것을 보여줍니다.

부문별 리뷰

맞춤형 항체 서비스 시장은 서비스, 유형, 공급원, 용도, 최종사용자, 지역으로 구분됩니다. 서비스별로 시장은 항체 발굴, 항체 제작 및 정제, 항체 세분화 및 라벨링으로 나뉩니다. 유형에 따라서는 단클론항체, 폴리클로날 항체, 재조합 항체, 기타로 분류됩니다. 공급원에 따라 마우스, 토끼, 기타로 분류됩니다. 용도별로는 종양학, 감염학, 신경학, 면역학, 심혈관 질환, 기타로 분류됩니다. 최종 사용자에 따라 제약 및 생명공학 기업, 학술 및 연구기관, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

서비스별로는 항체 개발 부문이 2023년 시장을 장악했습니다.

유형별로는 단클론항체 부문이 2023년 시장의 주요 주주였습니다.

공급원별로는 토끼 부문이 2023년 시장에서 높은 점유율을 차지했습니다.

응용 분야별로 보면, 2023년에는 감염성 질환 부문이 가장 높은 시장 점유율을 차지했습니다.

최종 사용자별로는 제약 및 생명공학 기업이 2023년 시장에서 높은 점유율을 차지할 것으로 보입니다.

지역별로는 북미가 2023년 가장 높은 수익을 올릴 것으로 예상됩니다.

본 보고서에서 가능한 커스터마이징(추가 비용 및 일정이 있습니다.)

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 프로파일 확대 목록
• 과거 시장 데이터
• 주요 진입기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 구도

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 맞춤형 항체 서비스 시장 : 서비스별

• 시장 개요
• 항체 개발
• 항체 생산 및 정제
• 항체 부문화 및 표지화

제5장 맞춤형 항체 서비스 시장 : 유형별

• 시장 개요
• 단클론항체
• 다중클론항체
• 재조합 항체
• 기타

제6장 맞춤형 항체 서비스 시장 : 공급원별

• 시장 개요
• 쥐
• 토끼
• 기타

제7장 맞춤형 항체 서비스 시장 : 용도별

• 시장 개요
• 종양학
• 감염증
• 신경학
• 면역학
• 심혈관질환
• 기타

제8장 맞춤형 항체 서비스 시장 : 최종사용자별

• 시장 개요
• 제약 기업 및 바이오테크놀러지 기업
• 학술기관 및 연구기관
• 기타

제9장 맞춤형 항체 서비스 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 맞춤형 항체 서비스 시장
  • 캐나다 맞춤형 항체 서비스 시장
  • 멕시코 맞춤형 항체 서비스 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일 맞춤형 항체 서비스 시장
  • 프랑스 맞춤형 항체 서비스 시장
  • 영국 맞춤형 항체 서비스 시장
  • 이탈리아 맞춤형 항체 서비스 시장
  • 스페인 맞춤형 항체 서비스 시장
  • 기타 유럽 맞춤형 항체 서비스 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본 맞춤형 항체 서비스 시장
  • 중국 맞춤형 항체 서비스 시장
  • 인도 맞춤형 항체 서비스 시장
  • 호주 항체 서비스 시장
  • 한국 맞춤형 항체 서비스 시장
  • 기타 아시아태평양 맞춤형 항체 서비스 시장
• 라틴아메리카/중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질 맞춤형 항체 서비스 시장
  • 사우디아라비아 맞춤형 항체 서비스 시장
  • 남아프리카공화국 맞춤형 항체 서비스 시장
  • 기타 라틴아메리카/중동 및 아프리카 맞춤형 항체 서비스 시장

제10장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제11장 기업 개요

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Sino Biological, Inc.
• Bio-Rad Laboratories, Inc
• Kaneka Eurogentec S.A.
• YenZym Antibodies, LLC.
• OriGene Technologies, Inc.
• Laboratory Corporation of America Holdings.
• GenScript

LSH

영문 목차

영문목차

Custom Antibody Services Market

The custom antibody services market was valued at $0.6 billion in 2023 and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Custom antibody services involve producing distinguished antibodies as per user requirements. The antibodies are specifically tailored for diagnostic, research, and therapeutic purposes. A key benefit of utilizing custom antibody services is the attainability of specificity in antibodies against antigens, resulting in improved & reliable experimental results. In addition, the flexibility of integrating different modifications into the antibodies attracts clients to benefit from the custom antibody services.

Increase in the popularity of personalized medicine for targeted therapies is rising the adoption of custom antibody services in the healthcare field. In addition, with surging expenditure in the pharmaceutical and biotech sectors for the strengthening of their R&D activities, the growth of the market is being driven considerably. The future of the custom antibody services market is anticipated to be redefined by recombinant technology and novel antibody trends. AI and ML algorithm are poised to assist in the designing of antibodies and develop next-generational antibodies such as single domain antibodies, bispecific antibodies, and antibody fragments.

However, the high cost of antibody production and extended development time hamper the growth of the custom antibody services market. In addition, the quality control measures and validation processes established for the approval of antibodies are highly rigorous and time-consuming. Efficient compliance with such standards delays the growth of the market. Contrarily, with rising investments on drug development and R&D, the custom antibody services market is anticipated to witness several lucrative growth opportunities. According to Statista, a global data and business intelligence platform, the U.S. spent an estimated amount of $603 billion on medicine in 2022. Furthermore, pharma companies in the U.S. spend approximately 21% of their revenue on R&D activities. Such expenditures indicate a promising future for the custom antibody services market.

Segment Review

The custom antibody services market is segmented into service, type, source, application, end user, and region. On the basis of service, the market is divided into antibody development, antibody production & purification, and antibody fragmentation & labeling. As per type, it is classified into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others. Depending on source, it is categorized into mice, rabbit, and others. According to application, it is divided into oncology, infectious diseases, neurology, immunology, cardiovascular diseases, and others. By end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the antibody development segment dominated the market in 2023.

As per type, the monoclonal antibodies segment was the major shareholder of the market in 2023.

Depending on source, the rabbit segment held a high share in the market in 2023.

According to application, the infectious diseases segment accounted for a high share in the market in 2023.

By end user, the pharmaceutical & biotechnology companies segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global custom antibody services market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Sino Biological, Inc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., OriGene Technologies, Inc., Laboratory Corporation of America Holdings., and GenScript. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Service

• Antibody Development
• Antibody Production and Purification
• Antibody Fragmentation and Labeling

By Type

• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Others

By Source

• Mice
• Rabbit
• Others

By Application

• Oncology
• Infectious Diseases
• Neurology
• Immunology
• Cardiovascular Diseases
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Sino Biological, Inc.
• Bio-Rad Laboratories, Inc
• Kaneka Eurogentec S.A.
• YenZym Antibodies, LLC.
• OriGene Technologies, Inc.
• Laboratory Corporation of America Holdings.
• GenScript

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Service
• 4.2. Antibody Development
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Antibody Production And Purification
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Antibody Fragmentation And Labeling
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: CUSTOM ANTIBODY SERVICES MARKET, BY TYPE

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Type
• 5.2. Monoclonal Antibodies
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Polyclonal Antibodies
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Recombinant Antibodies
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Others
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Source
• 6.2. Mice
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Rabbit
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Others
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Application
• 7.2. Oncology
  • 7.2.1. Key Market Trends, Growth Factors and Opportunities
  • 7.2.2. Market Size and Forecast, By Region
  • 7.2.3. Market Share Analysis, By Country
• 7.3. Infectious Diseases
  • 7.3.1. Key Market Trends, Growth Factors and Opportunities
  • 7.3.2. Market Size and Forecast, By Region
  • 7.3.3. Market Share Analysis, By Country
• 7.4. Neurology
  • 7.4.1. Key Market Trends, Growth Factors and Opportunities
  • 7.4.2. Market Size and Forecast, By Region
  • 7.4.3. Market Share Analysis, By Country
• 7.5. Immunology
  • 7.5.1. Key Market Trends, Growth Factors and Opportunities
  • 7.5.2. Market Size and Forecast, By Region
  • 7.5.3. Market Share Analysis, By Country
• 7.6. Cardiovascular Diseases
  • 7.6.1. Key Market Trends, Growth Factors and Opportunities
  • 7.6.2. Market Size and Forecast, By Region
  • 7.6.3. Market Share Analysis, By Country
• 7.7. Others
  • 7.7.1. Key Market Trends, Growth Factors and Opportunities
  • 7.7.2. Market Size and Forecast, By Region
  • 7.7.3. Market Share Analysis, By Country

CHAPTER 8: CUSTOM ANTIBODY SERVICES MARKET, BY END USER

• 8.1. Market Overview
  • 8.1.1 Market Size and Forecast, By End User
• 8.2. Pharmaceutical And Biotechnology Companies
  • 8.2.1. Key Market Trends, Growth Factors and Opportunities
  • 8.2.2. Market Size and Forecast, By Region
  • 8.2.3. Market Share Analysis, By Country
• 8.3. Academic And Research Institutes
  • 8.3.1. Key Market Trends, Growth Factors and Opportunities
  • 8.3.2. Market Size and Forecast, By Region
  • 8.3.3. Market Share Analysis, By Country
• 8.4. Others
  • 8.4.1. Key Market Trends, Growth Factors and Opportunities
  • 8.4.2. Market Size and Forecast, By Region
  • 8.4.3. Market Share Analysis, By Country

CHAPTER 9: CUSTOM ANTIBODY SERVICES MARKET, BY REGION

• 9.1. Market Overview
  • 9.1.1 Market Size and Forecast, By Region
• 9.2. North America
  • 9.2.1. Key Market Trends and Opportunities
  • 9.2.2. Market Size and Forecast, By Service
  • 9.2.3. Market Size and Forecast, By Type
  • 9.2.4. Market Size and Forecast, By Source
  • 9.2.5. Market Size and Forecast, By Application
  • 9.2.6. Market Size and Forecast, By End User
  • 9.2.7. Market Size and Forecast, By Country
  • 9.2.8. U.S. Custom Antibody Services Market
    • 9.2.8.1. Market Size and Forecast, By Service
    • 9.2.8.2. Market Size and Forecast, By Type
    • 9.2.8.3. Market Size and Forecast, By Source
    • 9.2.8.4. Market Size and Forecast, By Application
    • 9.2.8.5. Market Size and Forecast, By End User
  • 9.2.9. Canada Custom Antibody Services Market
    • 9.2.9.1. Market Size and Forecast, By Service
    • 9.2.9.2. Market Size and Forecast, By Type
    • 9.2.9.3. Market Size and Forecast, By Source
    • 9.2.9.4. Market Size and Forecast, By Application
    • 9.2.9.5. Market Size and Forecast, By End User
  • 9.2.10. Mexico Custom Antibody Services Market
    • 9.2.10.1. Market Size and Forecast, By Service
    • 9.2.10.2. Market Size and Forecast, By Type
    • 9.2.10.3. Market Size and Forecast, By Source
    • 9.2.10.4. Market Size and Forecast, By Application
    • 9.2.10.5. Market Size and Forecast, By End User
• 9.3. Europe
  • 9.3.1. Key Market Trends and Opportunities
  • 9.3.2. Market Size and Forecast, By Service
  • 9.3.3. Market Size and Forecast, By Type
  • 9.3.4. Market Size and Forecast, By Source
  • 9.3.5. Market Size and Forecast, By Application
  • 9.3.6. Market Size and Forecast, By End User
  • 9.3.7. Market Size and Forecast, By Country
  • 9.3.8. Germany Custom Antibody Services Market
    • 9.3.8.1. Market Size and Forecast, By Service
    • 9.3.8.2. Market Size and Forecast, By Type
    • 9.3.8.3. Market Size and Forecast, By Source
    • 9.3.8.4. Market Size and Forecast, By Application
    • 9.3.8.5. Market Size and Forecast, By End User
  • 9.3.9. France Custom Antibody Services Market
    • 9.3.9.1. Market Size and Forecast, By Service
    • 9.3.9.2. Market Size and Forecast, By Type
    • 9.3.9.3. Market Size and Forecast, By Source
    • 9.3.9.4. Market Size and Forecast, By Application
    • 9.3.9.5. Market Size and Forecast, By End User
  • 9.3.10. UK Custom Antibody Services Market
    • 9.3.10.1. Market Size and Forecast, By Service
    • 9.3.10.2. Market Size and Forecast, By Type
    • 9.3.10.3. Market Size and Forecast, By Source
    • 9.3.10.4. Market Size and Forecast, By Application
    • 9.3.10.5. Market Size and Forecast, By End User
  • 9.3.11. Italy Custom Antibody Services Market
    • 9.3.11.1. Market Size and Forecast, By Service
    • 9.3.11.2. Market Size and Forecast, By Type
    • 9.3.11.3. Market Size and Forecast, By Source
    • 9.3.11.4. Market Size and Forecast, By Application
    • 9.3.11.5. Market Size and Forecast, By End User
  • 9.3.12. Spain Custom Antibody Services Market
    • 9.3.12.1. Market Size and Forecast, By Service
    • 9.3.12.2. Market Size and Forecast, By Type
    • 9.3.12.3. Market Size and Forecast, By Source
    • 9.3.12.4. Market Size and Forecast, By Application
    • 9.3.12.5. Market Size and Forecast, By End User
  • 9.3.13. Rest of Europe Custom Antibody Services Market
    • 9.3.13.1. Market Size and Forecast, By Service
    • 9.3.13.2. Market Size and Forecast, By Type
    • 9.3.13.3. Market Size and Forecast, By Source
    • 9.3.13.4. Market Size and Forecast, By Application
    • 9.3.13.5. Market Size and Forecast, By End User
• 9.4. Asia-Pacific
  • 9.4.1. Key Market Trends and Opportunities
  • 9.4.2. Market Size and Forecast, By Service
  • 9.4.3. Market Size and Forecast, By Type
  • 9.4.4. Market Size and Forecast, By Source
  • 9.4.5. Market Size and Forecast, By Application
  • 9.4.6. Market Size and Forecast, By End User
  • 9.4.7. Market Size and Forecast, By Country
  • 9.4.8. Japan Custom Antibody Services Market
    • 9.4.8.1. Market Size and Forecast, By Service
    • 9.4.8.2. Market Size and Forecast, By Type
    • 9.4.8.3. Market Size and Forecast, By Source
    • 9.4.8.4. Market Size and Forecast, By Application
    • 9.4.8.5. Market Size and Forecast, By End User
  • 9.4.9. China Custom Antibody Services Market
    • 9.4.9.1. Market Size and Forecast, By Service
    • 9.4.9.2. Market Size and Forecast, By Type
    • 9.4.9.3. Market Size and Forecast, By Source
    • 9.4.9.4. Market Size and Forecast, By Application
    • 9.4.9.5. Market Size and Forecast, By End User
  • 9.4.10. India Custom Antibody Services Market
    • 9.4.10.1. Market Size and Forecast, By Service
    • 9.4.10.2. Market Size and Forecast, By Type
    • 9.4.10.3. Market Size and Forecast, By Source
    • 9.4.10.4. Market Size and Forecast, By Application
    • 9.4.10.5. Market Size and Forecast, By End User
  • 9.4.11. Australia Custom Antibody Services Market
    • 9.4.11.1. Market Size and Forecast, By Service
    • 9.4.11.2. Market Size and Forecast, By Type
    • 9.4.11.3. Market Size and Forecast, By Source
    • 9.4.11.4. Market Size and Forecast, By Application
    • 9.4.11.5. Market Size and Forecast, By End User
  • 9.4.12. South Korea Custom Antibody Services Market
    • 9.4.12.1. Market Size and Forecast, By Service
    • 9.4.12.2. Market Size and Forecast, By Type
    • 9.4.12.3. Market Size and Forecast, By Source
    • 9.4.12.4. Market Size and Forecast, By Application
    • 9.4.12.5. Market Size and Forecast, By End User
  • 9.4.13. Rest of Asia-Pacific Custom Antibody Services Market
    • 9.4.13.1. Market Size and Forecast, By Service
    • 9.4.13.2. Market Size and Forecast, By Type
    • 9.4.13.3. Market Size and Forecast, By Source
    • 9.4.13.4. Market Size and Forecast, By Application
    • 9.4.13.5. Market Size and Forecast, By End User
• 9.5. LAMEA
  • 9.5.1. Key Market Trends and Opportunities
  • 9.5.2. Market Size and Forecast, By Service
  • 9.5.3. Market Size and Forecast, By Type
  • 9.5.4. Market Size and Forecast, By Source
  • 9.5.5. Market Size and Forecast, By Application
  • 9.5.6. Market Size and Forecast, By End User
  • 9.5.7. Market Size and Forecast, By Country
  • 9.5.8. Brazil Custom Antibody Services Market
    • 9.5.8.1. Market Size and Forecast, By Service
    • 9.5.8.2. Market Size and Forecast, By Type
    • 9.5.8.3. Market Size and Forecast, By Source
    • 9.5.8.4. Market Size and Forecast, By Application
    • 9.5.8.5. Market Size and Forecast, By End User
  • 9.5.9. Saudi Arabia Custom Antibody Services Market
    • 9.5.9.1. Market Size and Forecast, By Service
    • 9.5.9.2. Market Size and Forecast, By Type
    • 9.5.9.3. Market Size and Forecast, By Source
    • 9.5.9.4. Market Size and Forecast, By Application
    • 9.5.9.5. Market Size and Forecast, By End User
  • 9.5.10. South Africa Custom Antibody Services Market
    • 9.5.10.1. Market Size and Forecast, By Service
    • 9.5.10.2. Market Size and Forecast, By Type
    • 9.5.10.3. Market Size and Forecast, By Source
    • 9.5.10.4. Market Size and Forecast, By Application
    • 9.5.10.5. Market Size and Forecast, By End User
  • 9.5.11. Rest of LAMEA Custom Antibody Services Market
    • 9.5.11.1. Market Size and Forecast, By Service
    • 9.5.11.2. Market Size and Forecast, By Type
    • 9.5.11.3. Market Size and Forecast, By Source
    • 9.5.11.4. Market Size and Forecast, By Application
    • 9.5.11.5. Market Size and Forecast, By End User

CHAPTER 10: COMPETITIVE LANDSCAPE

• 10.1. Introduction
• 10.2. Top Winning Strategies
• 10.3. Product Mapping of Top 10 Player
• 10.4. Competitive Dashboard
• 10.5. Competitive Heatmap
• 10.6. Top Player Positioning, 2023

CHAPTER 11: COMPANY PROFILES

• 11.1. Thermo Fisher Scientific Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Key Executives
  • 11.1.3. Company Snapshot
  • 11.1.4. Operating Business Segments
  • 11.1.5. Product Portfolio
  • 11.1.6. Business Performance
  • 11.1.7. Key Strategic Moves and Developments
• 11.2. Merck KGaA
  • 11.2.1. Company Overview
  • 11.2.2. Key Executives
  • 11.2.3. Company Snapshot
  • 11.2.4. Operating Business Segments
  • 11.2.5. Product Portfolio
  • 11.2.6. Business Performance
  • 11.2.7. Key Strategic Moves and Developments
• 11.3. Agilent Technologies, Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Key Executives
  • 11.3.3. Company Snapshot
  • 11.3.4. Operating Business Segments
  • 11.3.5. Product Portfolio
  • 11.3.6. Business Performance
  • 11.3.7. Key Strategic Moves and Developments
• 11.4. Sino Biological, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Key Executives
  • 11.4.3. Company Snapshot
  • 11.4.4. Operating Business Segments
  • 11.4.5. Product Portfolio
  • 11.4.6. Business Performance
  • 11.4.7. Key Strategic Moves and Developments
• 11.5. Bio-Rad Laboratories, Inc
  • 11.5.1. Company Overview
  • 11.5.2. Key Executives
  • 11.5.3. Company Snapshot
  • 11.5.4. Operating Business Segments
  • 11.5.5. Product Portfolio
  • 11.5.6. Business Performance
  • 11.5.7. Key Strategic Moves and Developments
• 11.6. Kaneka Eurogentec S.A.
  • 11.6.1. Company Overview
  • 11.6.2. Key Executives
  • 11.6.3. Company Snapshot
  • 11.6.4. Operating Business Segments
  • 11.6.5. Product Portfolio
  • 11.6.6. Business Performance
  • 11.6.7. Key Strategic Moves and Developments
• 11.7. YenZym Antibodies, LLC.
  • 11.7.1. Company Overview
  • 11.7.2. Key Executives
  • 11.7.3. Company Snapshot
  • 11.7.4. Operating Business Segments
  • 11.7.5. Product Portfolio
  • 11.7.6. Business Performance
  • 11.7.7. Key Strategic Moves and Developments
• 11.8. OriGene Technologies, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Key Executives
  • 11.8.3. Company Snapshot
  • 11.8.4. Operating Business Segments
  • 11.8.5. Product Portfolio
  • 11.8.6. Business Performance
  • 11.8.7. Key Strategic Moves and Developments
• 11.9. Laboratory Corporation of America Holdings.
  • 11.9.1. Company Overview
  • 11.9.2. Key Executives
  • 11.9.3. Company Snapshot
  • 11.9.4. Operating Business Segments
  • 11.9.5. Product Portfolio
  • 11.9.6. Business Performance
  • 11.9.7. Key Strategic Moves and Developments
• 11.10. GenScript
  • 11.10.1. Company Overview
  • 11.10.2. Key Executives
  • 11.10.3. Company Snapshot
  • 11.10.4. Operating Business Segments
  • 11.10.5. Product Portfolio
  • 11.10.6. Business Performance
  • 11.10.7. Key Strategic Moves and Developments

관련자료